nitazoxanide
nitazoxanide: sourced relationships with 1 company · 1 clinical trial tracked · 1 FDA decision.
nitazoxanide evidence translation
What we can confirm
1 FDA record · 1 tracked trial
What it means
What to watch
Prepared research question
How could nitazoxanide → ANIP affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| ANI PHARMACEUTICALS INC (ANIP) Reported 2025-02-03 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (1)
Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Primary endpoint: Rate of viral clearance for interventions relative to the no study arm (This is a superiority comparison)
Frequently asked questions
Which companies have sourced relationships with nitazoxanide?
nitazoxanide has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC.
How many clinical trials involve nitazoxanide?
BioSniper tracks 1 clinical trial involving nitazoxanide.
What is nitazoxanide's latest FDA decision?
The most recent tracked FDA decision for nitazoxanide is Approval, dated February 3, 2025.